Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Cafiwel (Caffeine Citrate Solution 20 mg)
Cafiwel is a medically essential therapy used in neonatal intensive care to treat apnea of prematurity. It helps stimulate breathing in premature infants and supports normal respiratory function.
Uses of Cafiwel
Manages apnea in premature infants, reducing breathing interruptions.
Supports neonatal respiratory therapy in intensive care units.
Improves oxygenation and reduces the need for mechanical ventilation.
Benefits of Cafiwel
Safe and well-tolerated for neonatal use.
Rapid onset of action for effective respiratory stimulation.
Reduces the risk of prolonged ventilator dependency in preterm infants.
Mechanism of Action of Cafiwel
Acts as a central nervous system stimulant, enhancing respiratory drive.
Blocks adenosine receptors, reducing apnea episodes.
Cafiwel – Essential respiratory support for premature infants!